The Latest Breaking News from Malaria

Uptick in cases in Udupi and DK, says Minister

In tonight's edition: Mali puts a stop to rotations of UN peacekeepers from the organisation's MINUSMA mission. Five former members of the Gambia's Intelligence Agency have been sentenced to death for the 2016 killing of a political activist called Solo Sandeng. And three years after the launch of a groundbreaking…

After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.

Plants have directly contributed to the development of important drugs. The antimalarial treatment artemisinin, pain medication morphine, and cancer chemotherapy taxol are just three examples of drugs derived from plants. Africa is endowed with up to 45,000 plant species – about 25% of the world’s plant genetic resources. More than…

Most of the global cases of sickle cell disease are diagnosed in African countries. The Economist Intelligence Unit – the research and analysis division of the Economist media group – estimated that in 2020 the total annual cost of treatment and impact on the economy of sickle cell disease across…

As the world warms, diseases transmitted by insects may spread, but prevention strategies can break the link.

Mosquitoes are the world’s deadliest animal. Over 1 million deaths per year are attributed to mosquito-borne diseases, including malaria, yellow fever, dengue fever, Zika and chikungunya fever.

Africa has great potential for drug discovery. The continent has natural resources, indigenous knowledge and human capacity. And it has the need: it bears more than 20% of the global disease burden. There are many internationally recognised African scientists undertaking cutting edge research. But a lack of resources makes it…

The disease is a leading killer of under fives across Africa. But trials for a new vaccine suggest an end to the death toll could be in sight

Leaders of Commonwealth nations are meeting in Rwanda in a summit that promises to tackle climate change, tropical diseases and other challenges deepened by the COVID-19 pandemic

Novartis AG (NYSE:NVS) is pledging $250 million into R&D for new treatments of neglected tropical diseases (NTD) and malaria, with an aim to eliminate these diseases. "Over the past decade, great progress has been made against NTDs, but there is still a lot more work to be done," CEO Vas Narasimhan said. Novartis…